natgillin/translations-raw huggingface dataset:
Intervet UK Limited Walton Manor, Walton, Milton Keynes, Buckinghamshire, MK7 7AJ UNITED KINGDOM
Intervet UK limited Walton Manor, Walton, Milton Keynes, Buckinghamshire, MK7 7AJ Ujedinjeno Kraljevstvo
Step 2: The dog should be standing or lying with its back horizontal during application.
Korak 2: Pas treba stajati ili ležati s leđima u horizontalnom položaju tijekom primjene.
The product should be applied on cats up to 6.25 kg body weight in one spot at the base of the skull and in two spots on cats greater than 6.25 kg bodyweight.
Proizvod treba aplicirati na mačku do 6,25 kg tjelesne mase na jedno mjesto na stražnji dio glave i na dva mjesta ako je mačka teža od 6,25 kg tjelesne mase.
The pipette is open and ready for application when the breaking of the seal is felt.
Pipeta je otvorena i spremna za primjenu kada primijetite pucanje folije.
The dog should be observed during administration to confirm that the tablet is swallowed.
Prilikom primjene treba promatrati psa da bismo bili sigurni da je tableta progutana.
A plateau is seen in plasma between 7 and 63 days post administration, after which concentrations decline slowly.
Najveća koncentracija je uočena u plazmi između 7 i 63 dana nakon aplikacije nakon čega polako opada.
Fluralaner has a high potency against ticks and fleas by exposure via feeding, i.e. it is systemically active on target parasites.
Fluralaner ima visoku potentnost protiv krpelja i buha, izloženih putem hranjenja, npr. sustavno je aktivan u ciljnih parazita.
The sachets should only be opened immediately prior to use.
Vrećice treba otvarati samo neposredno prije upotrebe.
Convulsions and lethargy has been reported very rarely in spontaneous (pharmacovigilance) reports.
Vrlo rijetko su prijavljene letargija i konvulzije u spontanim (farmakovigilancijskim) izvješćima.
In molecular on-target studies on insect GABA receptors of flea and fly, fluralaner is not affected by dieldrin resistance.
U molekularnim ispitivanjima ciljanim na GABA receptore buha i muha, dieldrinska rezistencija ne utječe na fluralaner.
Keep the product in the original packaging until use, in order to prevent children from getting direct access to the product.
Čuvati proizvod u originalnom pakiranju do upotrebe, kako bi djeci onemogućili direktan pristup proizvodu.
Each ml contains 280 mg fluralaner.
Svaki ml sadrži 280 mg fluralanera.
People with a sensitive skin or known allergy in general e.g. to other veterinary medicinal products of this type should handle the veterinary medicinal product as well as treated animals with caution.
Ljudi s osjetljivom kožom ili poznatom alergijom, općenito trebaju oprezno upotrebljavati veterinarsko-medicinske proizvode ovog tipa te oprezno rukovati s tretiranim životinjama.
For optimal control of tick and flea infestation, the product should be administered at intervals of 12 weeks.
Za optimalnu kontrolu infestacije buhama i krpeljima, proizvod treba primjenjivati u intervalima od 12 tjedana.
Convulsions and lethargy has been reported very rarely in spontaneous reports.
Vrlo rijetko su prijavljene letargija i konvulzije u spontanim izvješćima.
The cap will stay on the pipette; it is not possible to remove it.
Zatvarač će ostati na pipeti, nije ga moguće odvojiti.
The prolonged persistence and slow elimination from plasma (t1/2 = 12 days) and the lack of extensive metabolism provide effective concentrations of fluralaner for the duration of the inter-dosing interval.
Produžena perzistentnost i spora eliminacija iz plazme (t1/2 = 12 dana) i nedostatak ekstenzivnog metabolizma osigurava učinkovitu koncentraciju fluralanera između 2 intervala doziranja.
Parasites need to start feeding on the host to become exposed to fluralaner; therefore the risk of the transmission of parasite borne diseases cannot be excluded.
Paraziti se moraju početi hraniti na domaćinu kako bi bili izloženi fluralaneru; stoga se ne može isključiti rizik prijenosa bolesti prenosivih parazitima.
Each pipette delivers:
Svaka pipeta sadržava:
PARTICULARS TO APPEAR ON THE OUTER PACKAGE Carton Box
PODACI NA VANJSKOM PAKOVANJU Kartonska kutija
Intervet GesmbH Siemensstrasse 107 1210 Vienna AUSTRIA
Tablete za žvakanje: Intervet GesmbH Siemensstrasse 107 1210 Beč
Fleas and ticks must attach to the host and commence feeding in order to be exposed to the active substance.
Krpelji i buhe moraju se prihvatiti na domaćina i započeti hranjenje kako bi bili izloženi djelatnoj tvari.
Clear colourless to yellow solution.
Bezbojna do žućkasta otopina.
Fluralaner is systemically distributed and reaches the highest concentrations in fat, followed by liver, kidney and muscle.
Fluralaner je sustavno raspoređen te svoju najveću koncentraciju postiže u masnom tkivu, nakon čega slijede jetra, bubrezi i mišići.
The flea life cycle is broken due to the rapid onset of action and long lasting efficacy against adult fleas on the animal and the absence of viable egg production.
Životni ciklus buha prekinut je uslijed trenutnog i dugotrajnog učinka protiv odraslih buha na životinjama te nemogućnosti proizvodnje održivih jajašaca.
Apply to skin.
Za nakapavanje na kožu.
For optimal control of flea infestation, the veterinary medicinal product should be administered at intervals of 12 weeks.
Za optimalnu kontrolu infestacije buhama, veterinarsko-medicinski proizvod treba primjenjivati u intervalima od 12 tjedana.
An in vitro study also demonstrated that very low concentrations of fluralaner stop the production of viable eggs by fleas.
In vitro ispitivanja također su pokazala da je mala koncentracija fluralanera zaustavila proizvodnju održivih jajašca buha.
Bodyweight of dog (kg)
Tjelesna težina pasa (kg)
Wear gloves when handling and administering this product.
Nositi zaštitne rukavice prilikom rukovanja i primjene ovog proizvoda.
Fluralaner is readily systemically absorbed from the topical administration site, reaching maximum concentrations in plasma between 3 and 21 days after administration.
Fluralaner je odmah apsorbiran nakon primjene na mjesto za nakapavanje, a doseže maksimum koncentracije u plazmi između 3 i 21 dan nakon primjene.
The product should not be used by persons with a hypersensitivity to the active substance or to any of the excipients (see contraindications, section 4.3).
Proizvod ne smiju upotrebljavati osobe preosjetljive na djelatnu tvar ili bilo koju od pomoćnih tvari (vidjeti pod kontraindikacije, odjeljak 4.3 ).
Interaction with other medicinal products and other forms of interaction: None known.
Interakcije s drugim medicinskim proizvodima ili drugi oblici interakcije Nisu poznate.
Manufacturer responsible for batch release: Intervet GesmbH
Proizvođač odgovoran za puštanje serije u promet: Intervet GesmbH
Step 3: Squeeze the pipette gently and apply the entire contents directly to the cat's skin.
Korak 3: Nježno istisnite pipetu i aplicirajte cijelu količinu direktno na ili na kožu mačke.
and Rhipicephalus sanguineus) and fleas (Ctenocephalides spp.)
Rhipicephalus sanguineus) i buha (Ctenocephalides spp.) na psima.
Some marbling, speckles or both may be visible.
Poneka mrlja ili pjega mogu biti uočljive.
QUALITATIVE AND QUANTITATIVE COMPOSITION Active substance:
KVALITATIVNI I KVANTITATIVNI SASTAV DJELATNIH TVARI
Treatment schedule:
Raspored liječenja:
Bodyweight of cat (kg)
Tjelesna težina mačaka (kg)
Soya-bean oil
Sojino ulje
The printed package leaflet of the medicinal product must state the name and address of the manufacturer responsible for the release of the concerned batch.
U priloženoj uputi veterinarsko medicinskog proizvoda treba biti navedeno ime i adresa proizvođača odgovornog za puštanje serije u promet.
Place the pipette tip vertically against the skin between the shoulder blades of the dog.
Stavite vrh pipete okomito na kožu između lopatica psa.
Pharmacotherapeutic group: Ectoparasiticides for systemic use ATCvet code: QP53B E02
Farmakoterapijska grupa: ektoparaziticidi za sustavnu upotrebu ATCvet kod: QP53BE02
The following other signs shortly after administration were uncommonly observed: apathy/tremors/anorexia (0.9% of treated cats) or vomiting/hypersalivation (0.4% of treated cats).
Nakon primjene manje često su uočene sljedeće nuspojave: apatija/tremor/anoreksija (0,9% tretiranih mačaka) ili povraćanje/pojačano slinjenje (0,4% tretiranih mačaka).
Following oral administration, fluralaner is readily absorbed reaching maximum plasma concentrations within 1 day.
Sljedeći peroralnu primjenu, fluralaner je odmah apsorbiran i postiže maksimalnu koncentraciju u plazmi unutar jednog dana.
Manufacturer responsible for batch release: Intervet Productions
Proizvođač odgovoran za puštanje serije u promet: Intervet Productions
Fluralaner is a potent inhibitor of parts of the arthropod nervous system by acting antagonistically on ligand-gated chloride channels (GABA-receptor and glutamate-receptor).
Fluralaner je jak inhibitor dijelova živčanog sustava artropoda koji djeluje antagonistički na ligandom regulirane kloridne kanale (GABA-receptori i glutamat receptori).
In in vitro bio-assays, fluralaner is not affected by proven field resistances against amidines (tick), organophosphates (tick, mite), cyclodienes (tick, flea, fly), macrocyclic lactones (sea lice), phenylpyrazoles (tick, flea), benzophenyl ureas (tick), pyrethroids (tick, mite) and carbamates (mite).
U in-vitro bio-testovima, fluralaner nije bio zahvaćen dokazanom terenskom rezistencijom protiv amidina (krpelji), organofosfata (krpelj, grinje), ciklodina (krpelj, buha, muha), makrocikličkih laktona (morske uši), fenilpirazola (krpelj, buha), benzofenil uree (krpelj), piretroida (krpelj, grinje) i karbamata (grinje).
Cardboard box with 1 aluminium foil blister sealed with PET aluminium foil lid stock containing 1, 2 or 4 chewable tablets.
Kartonska kutija s 1 aluminijskim blisterom, zapečaćenim PET aluminijskom folijom koji sadrži 1, 2 ili 4 tablete za žvakanje.
Do not use this veterinary medicinal product after the expiry date stated on the packaging after EXP.
Ne primjenjivati veterinarsko-medicinski proizvod nakon isteka roka valjanosti koji je naznačen na pakovanju nakon oznake EXP.
Newly emerged fleas on a dog are killed before viable eggs are produced.
Tek izlegnute buhe na psu ubijene su prije nego što su uspjele proizvesti održiva jajašca.
Treatment schedule
Raspored tretmana
Fluralaner is readily absorbed from the topical administration site into the hair, skin and subjacent tissues, from where it is slowly absorbed into the vascular system.
Sljedeći primjenu na koži, fluralaner je odmah apsorbiran u dlaci, koži i okolnim tkivima odakle je polako apsorbiran u krvni sustav.
Newly emerged fleas on a cat are killed before viable eggs are produced.
Tek izlegnute buhe na mački ubijene su prije nego što su uspjele proizvesti održiva jajašca.
Oral uptake of the product at the maximum recommended dose of 93 mg fluralaner/kg body weight was well tolerated in cats, apart from some self-limiting salivation and coughing or vomiting immediately after administration.
Peroralnu upotrebu maksimalne doze od 93 mg fluralanera/kg tjelesne težine mačke dobro podnose, osim povećanog slinjenja i kašlja ili povraćanja odmah nakon uzimanja.
Step 3: Squeeze the pipette gently and apply the entire contents directly to the dog's skin in one (when volume is small) or several spots along the dog's dorsal line from the shoulder to the base of the tail.
Korak 3: Nježno istisnite pipetu i aplicirajte cijelu količinu direktno na jedno (kod manjih sadržaja) ili na nekoliko mjesta duž leđne linije od lopatice do vrha repa.
Fluralaner is highly bound to plasma proteins and might compete with other highly bound active substances such as non-steroidal anti-inflammatory drugs (NSAIDs) and the coumarin derivative warfarin.
Fluralaner se čvrsto veže za proteine plazme te može konkurirati ostalim čvrsto vezujućim djelatnim tvarima poput nesteroidnih protuupalnih lijekova (NSPUL) i kumarinskog derivata varfarina.
This product is for topical use and should not be administered orally.
Proizvod je namijenjen za primjenu na koži i ne smije se davati peroralno.
If skin reactions occur, consult a physician and show them the product packaging.
Ukoliko dođe do kožnih reakcija, posavjetujte se s liječnikom i pokažite mu uputu.
In case of accidental ingestion, seek medical advice and show the package leaflet or the label to the physician.
U slučaju nehotičnog gutanja potražiti stručni savjet te liječniku pokazati uputu ili naljepnicu.
The frequency of adverse reactions is defined using the following convention: - very common (more than 1 in 10 animals treated displaying adverse reaction(s)) - common (more than 1 but less than 10 animals in 100 animals treated) - uncommon (more than 1 but less than 10 animals in 1,000 animals treated) - rare (more than 1 but less than 10 animals in 10,000 animals treated) - very rare (less than 1 animal in 10,000 animals treated, including isolated reports).
Učestalost nuspojava je određena sukladno sljedećim pravilima: - vrlo česte (više od 1 na 10 tretiranih životinja pokazuju nuspojave) - česte (više od 1 ali manje od 10 životinja na 100 tretiranih životinja) - manje česte (više od 1 ali manje od 10 životinja na 1.000 tretiranih životinja) - rijetke (više od 1 ali manje od 10 životinja na 10.000 tretiranih životinja) - vrlo rijetke (manje od 1 životinje na 10.000 tretiranih životinja, uključujući izolirane slučajeve).
EXP: {month/year}
ROK VALJANOSTI EXP {mjesec/godina}
Put on gloves.
Staviti rukavice.
0.4 ml 0.89 ml 1.79 ml
0,89 ml 1,79 ml
The product should not be used by persons with a hypersensitivity to the active substance or to any of the excipients (see section Contraindications).
Proizvod ne smiju upotrebljavati osobe preosjetljive na djelatnu tvar ili bilo koju od pomoćnih tvari (vidjeti odjeljak Kontraindikacije)
Wash hands thoroughly with soap and water immediately after use of the product.
Odmah nakon primjene proizvoda temeljito oprati ruke vodom i sapunom.
Oral uptake of the product at the maximum recommended dose was well tolerated in cats, apart from some self-limiting salivation and coughing or vomiting immediately after administration.
Peroralnu upotrebu maksimalne doze mačke dobro podnose, osim povećanog slinjenja i kašlja ili povraćanja odmah nakon uzimanja.
The pipettes should be kept in the outer packaging to prevent solvent loss or moisture uptake.
Pipete čuvati u vanjskom pakovanju da bi se izbjegao gubitak otopine ili upijanje vlage.
Unit dose pipette made of laminated aluminium/polypropylene foil closed with an HDPE cap and packed in a laminated aluminium foil sachet.
Jedinica doze pipeta, izrađena od laminirane aluminij / polipropilen folije zatvoreno s HDPE poklopcem i pakirno u laminirane aluminijske folijske vrećice.
This product is harmful after ingestion.
Ovaj proizvod je opasan u slučaju gutanja.
The frequency of adverse reactions is defined using the following convention: - very common (more than 1 in 10 animals treated displaying adverse reaction(s)) - common (more than 1 but less than 10 animals in 100 animals treated) - uncommon (more than 1 but less than 10 animals in 1,000 animals treated) - rare (more than 1 but less than 10 animals in 10,000 animals treated) - very rare (less than 1 animal in 10,000 animals treated, including isolated reports)
Učestalost nuspojava je određena sukladno sljedećim pravilima: - vrlo česte (više od 1 na 10 tretiranih životinja pokazuju nuspojave) - česte (više od 1 ali manje od 10 životinja na 100 tretiranih životinja) - manje česte (više od 1 ali manje od 10 životinja na 1.000 tretiranih životinja) - rijetke (više od 1 ali manje od 10 životinja na 10.000 tretiranih životinja)
It is efficacious against ticks (Ixodes spp., Dermacentor spp.
Učinkovit je protiv krpelja (Ixodes spp., Dermacentor spp. i
Safety was demonstrated in breeding, pregnant and lactating animals treated with overdoses of up to 3 times the maximum recommended dose.
Neškodljivost je dokazana u rasplodnih pasa, te kuja u laktaciji i graviditetu tretiranih s i do 3 x većim dozama od maksimalne preporučene doze.
Hypersensitivity reactions to the product have been reported in a small number of people.
Kod manjeg broja ljudi uočljiva je reakcija preosjetljivosti na proizvod.
Intervet International B. V. Wim de Körverstraat 35 5831 AN Boxmeer The Netherlands
Wim de Körverstraat 35 5831 AN Boxmeer Nizozemska
Strength and number of tablets to be administered
Jačina i broj tableta za primjenu
Administer Bravecto chewable tablets at or around the time of feeding.
Primijeniti Bravecto tablete za žvakanje u vrijeme hranjenja.
Strength and number of pipettes to be administered
Jačina i broj pipeta za primjenu
for small cats 1.2 - 2.8 kg for medium-sized cats >2.8 - 6.25 kg for large cats >6.25 - 12.5 kg
za male mačke 1,2 - 2,8 kg za srednje velike mačke >2,8 - 6,25 kg za velike mačke >6,25 - 12,5 kg
Keep the product in the original packaging until use in order to prevent children from getting access to the product.
Čuvati proizvod u originalnom pakovanju do primjene radi sprečavanja doticaja djece sa proizvodom.
Do not use this veterinary medicinal product after the expiry date which is stated on the blister after EXP.
Ne primjenjivati veterinarsko-medicinski proizvod nakon isteka roka valjanosti koji je naznačen na blisteru.
Intervet UK Limited Walton Manor, Walton, Milton Keynes, Buckinghamshire, MK7 7AJ United Kingdom
Intervet UK Limited Walton Manor, Walton, Milton Keynes,
The safety of the veterinary medicinal product has not been established during pregnancy and lactation.
Neškodljivost ovog veterinarsko-medicinskog proizvoda tijekom graviditeta i laktacije nije utvrđena.
Each chewable tablet contains:
Svaka pipeta sadrži:
MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS Sachet
OSNOVNI PODACI NAPISANI NA MALIM JEDINICAMA UNUTARNJIH PAKOVANJA
The product should not be administered at intervals shorter than 8 weeks as the safety at shorter intervals has not been tested.
Proizvod ne treba primjenjivati u intervalima kraćim od 8 tjedana jer neškodljivost u kraćim intervalima nije ispitana.
In order to avoid contact, disposable protective gloves obtained with this product at the point of sale must be worn when handling and administering the product.
Da bi izbjegli kontakt, treba nositi zaštitne rukavice prilikom rukovanja i primjene proizvoda , dostupne uz ovaj proizvod na mjestu prodaje.
If you notice any side effects, even those not already listed in this package leaflet or you think that the medicine has not worked, please inform your veterinary surgeon.
Ako zamijetite nuspojave ili druge simptome koji nisu opisani u uputi o VMP ili mislite da je proizvod nedjelotvoran, molimo obavijestite veterinara.
There were no findings on reproductive performance and no findings of concern on offspring viability when fluralaner was administered orally to Beagle dogs at overdoses of up to 3 times the maximum recommended dose (up to 168 mg/kg bodyweight of fluralaner).
Nije bilo nikakvog utjecaja na reproduktivne sposobnosti niti na održivost graviditeta kad je fluralaner bio peroralno primijenjen na biglovima u 3 x većoj dozi od maksimalne preporučene doze (do 168 mg/kg fluralanera/tjelesne težine).
The pipette should be held by the base or by the upper rigid portion below the cap in an upright position (tip up) for opening it.
Prilikom otvaranja pipetu treba držati po sredini ili pri gornjem čvrstom dijelu ispod zatvarača u uspravnom položaju.
The sachets should only be opened immediateley prior to use.
Vrećicu bi trebalo otvarati neposredno prije primjene.
The product contributes towards the control of environmental flea populations in areas to which treated cats have access.
Proizvod pomaže kontroli populacije buha u okolini tretiranih mačaka.
Avoid the application of more than 1 ml of solution at any one spot as it could cause some of the solution to run or drip off the dog.
Izbjegavati aplikaciju većeg sadržaja na jedno mjesto kako bi se izbjeglo curenje ili cijeđenje sa psa.
Bravecto should be administered in accordance with the following table (corresponding to a dose of 40 - 94 mg fluralaner/kg body weight):
Bravecto treba primjenjivati u skladu sa sljedećom tablicom (odgovarajuća doza od 40 - 94 mg fluralanera/kg tjelesne težine unutar pojedine skupine):
Pregnancy, lactation and fertility: Can be used in breeding, pregnant and lactating dogs.
Primjena tijekom graviditeta, laktacije ili nesenja Može se primjenjivati na rasplodne pse, te kuje u graviditetu i laktaciji.
EU/2/13/158/001 EU/2/13/158/002 EU/2/13/158/003 EU/2/13/158/004 EU/2/13/158/005 EU/2/13/158/006 EU/2/13/158/007 EU/2/13/158/008 EU/2/13/158/009 EU/2/13/158/010 EU/2/13/158/011 EU/2/13/158/012 EU/2/13/158/013
EU/2/13/158/001 EU/2/13/158/002 EU/2/13/158/003 EU/2/13/158/004 EU/2/13/158/005 EU/2/13/158/006 EU/2/13/158/007 EU/2/13/158/008 EU/2/13/158/009 EU/2/13/158/010
Place the pipette tip on the base of the skull of the cat.
Stavite vrh pipete na stražnji dio glave mačke (početak vrata).
Bravecto 112.5 mg (2-4.5 kg) Bravecto 250 mg (>4.5 -10 kg) Bravecto 500 mg (>10 -20 kg) Bravecto 1,000 mg (>20 -40 kg) Bravecto 1,400 mg (>40 -56 kg) fluralaner
Bravecto 112,5 mg (2-4,5 kg) Bravecto 250 mg (>4,5 -10 kg) Bravecto 500 mg (>10-20 kg) Bravecto 1000 mg (>20-40 kg) Bravecto 1400 mg (>40-56 kg)
Mild and transient gastrointestinal effects such as diarrhoea, vomiting, inappetence, and drooling were commonly observed in clinical trials (1.6% of treated dogs).
Prolazni gastrointestinalni simptomi poput proljeva, povraćanja, inapetencije i slinjenja, često su uočeni u kliničkim istraživanjima (1,6 % tretiranih pasa).
Shelf life of the veterinary medicinal product as packaged for sale: Bravecto 112.5 mg spot-on solution: 2 years Bravecto 250 mg / 500 mg spot-on solution: 3 years
Rok valjanosti veterinarsko-medicinskog proizvoda kad je zapakiran za prodaju: Bravecto 112,5 mg otopina za nakapavanje: 2 godine.
Avoid contact with skin, mouth and/or eye. Do not contact the application site until it is no longer noticeable.
Izbjegavati kontakt s kožom, ustima i/ili očima.
EU/2/13/158/001-015
EU/2/13/158/016-017 112,5 mg
The product contributes towards the control of environmental flea populations in areas to which treated dogs have access.
Proizvod pomaže kontroli populacije buha u okolini tretiranog psa.
Unchanged fluralaner is excreted in feces and to a very low extent in urine.
Glavni put eliminacije je izlučivanje nepromijenjenog fluralanera u fecesu a manji dio u urinu.
During clinical field testing, no interactions between Bravecto chewable tablets for dogs and routinely used veterinary medicinal products were observed.
Tijekom terenskih ispitivanja, nisu primijećene interakcije između Bravecto tableta za žvakanje za pse i rutinski korištenih veterinarsko medicinskih proizvoda.
Do not use in case of hypersensitivity to the active substance or to any of the excipients.
Ne primjenjivati u slučaju preosjetljivosti na djelatnu tvari ili na bilo koju od pomoćnih tvari.
For cats above 12.5 kg body weight, use a combination of two pipettes that most closely matches the body weight.
Za mačke iznad 12,5 kg tjelesne težine primjenjivati kombinaciju od 2 pipete koje najviše odgovaraju tjelesnoj težini.
In the absence of available data, this veterinary medicinal product should not be used on kitten less than 11 weeks old and /or cats weighing less than 1.2 kg.
U nedostatku dostupnih podataka, ovaj veterinarsko-medicinski proizvod ne upotrebljavati na mačićima do 11 tjedana starosti i/ili mačkama ispod 1,2 kg tjelesne mase.
Bravecto should be administered in accordance with the following table (corresponding to a dose of 25-56 mg fluralaner/kg bodyweight within one weight band):
Bravecto treba primjenjivati u skladu sa sljedećom tablicom (odgovarajuća doza od 25-56 mg fluralanera/kg tjelesne težine unutar pojedine skupine):
Skin rashes tingling or numbness have been reported in a small number of individuals after skin contact.
Poslije dodira s kožom kod manjeg broja ljudi prijavljene reakcije su bile osip po koži ili utrnulost.
Spot-on solution:
Način primjene: